Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR FOURTH QUARTER / FULL YEAR | 2024 ...
-
Bagsværd, Denmark, 27 February 2025 – The Annual General Meeting of Novo Nordisk A/S will be held on: Thursday 27 March 2024 at 14.00 (CET) The Annual General Meeting is held as a partially...
-
Longitudinal ALS patient data from APST Research will enable a more robust analysis of the effect of CNM-Au8 on NfL biomarkersAPST Research data includes thousands of people living with ALS including...
-
Finnvera-konserni, pörssitiedote, 21.2.2025 Finnvera-konsernin toimintakertomus ja tilinpäätös 2024 Rahoitus vuodentakaista alemmalla tasolla, odotukset tulevasta kysynnästä positiivisia –...
-
Finnvera Group, Stock Exchange Release, 21 February 2025 Finnvera Group’s Report of the Board of Directors and Financial Statements 2024 Level of financing reduced from previous year,...
-
Rational Funds proudly announces that the Rational Special Situations Income Fund (RFXIX) surpassed $1 Billion in AUM as of January 2025.
-
LAUPHEIM, Germany, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, today announced the...
-
NASDAQ FIRST NORTH GROWTH MARKET MEDDELELSE NR. 2/2025 København, den 19. februar 2025 FN2/2025 Kapitalforhøjelse – Nye aktier I forlængelse af FN1 vedrørende kapitalforhøjelsen meddeler...
-
Berlin, Germany, and Research Triangle Park, N.C., USA, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Not intended for UK Media Regenerative Medicine Advanced Therapy (RMAT) designation follows Phase Ib...
-
NASDAQ FIRST NORTH GROWTH MARKET MEDDELELSE NR. 1/2025 København, den 17. februar 2025 FN1/2025 Kapitalforhøjelse – Udnyttelse af warrants Bestyrelsen i FastPass har i dag besluttet at udnytte...